A blockbuster drug can be a major factor in a pharmaceutical company's success. However, it can also cause major problems for a company if the drug is discovered to have problematic side effects or is recalled after being released. This can result inlitigation, high legal fees, and significan...
Official answer: Severe asthma is when you require medium to high-dose inhaled corticosteroids combined with other longer-acting...
I asked around to my coworkers, and no one had an albuterol inhaler. However, someone did have an over the counter inhaler. I used it out of desperation, and it actually worked! I was so relieved. I didn't want to have to call an ambulance or something right in the middle of work...
“rescue inhaler” during an attack, while long-acting bronchodilators are taken daily to stave off attacks. Examples of daily maintenance inhalers include fluticasone propionate / salmeterol (Advair) and fluticasone furoate / vilanterol (Breo). The most common rescue inhaler is albuterol (Ventolin)...
(included in combination inhalers like Advair HFA and Symbicort) and/or leukotriene modifiers like Singulair (montelukast). If standard step-up therapies are insufficient for controlling your asthma, you may discuss some of the more recently discovered medications used to target eosinophils in ...
Combination inhaler therapy is now available for the treatment of asthma. These medications include Advair (fluticasone and salmeterol), Symbicort (budesonide and formoterol), and Dulera (mometasone and formoterol). Symbicort and Dulera use the standard MDI inhaler device with a dose counter. Advair ...
Some people with COPD who respond well to oral corticosteroids can be maintained on long-term inhaledsteroids. Advair and Symbicort contain steroids that can be inhaled. The use of these drugs is widespread, despite little evidence of efficacy in the treatment of COPD. Inhaled corticosteroids do ...
Trelegy Ellipta is the first once-daily single inhaler combining 3 ingredients for the treatment of COPD. In clinical studies, Trelegy Ellipta was shown to be highly effective in improving respiratory laboratory endpoints compared to placebo + fluticasone furoate/vilanterol. In safety analyses, no majo...